Evidence map›Paper›PMID 38453729›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Guiding principles on the education and practice of theranostics.

Thomas N B Pascual, Diana Paez, Andrei Iagaru, Gopi Gnanasegaran, Sze Ting Lee, Mike Sathekge, John M Buatti, Francesco Giammarile, Akram Al-Ibraheem, Manuela Arevalo Pardo and 23 more

Erratum issuedAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Ethical Precision in Nanoscale Brain Interfacing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Theranostics Implementation: Opportunities and Challenges.World journal of nuclear medicine · 2025
    Article
  11. Review
  12. ARTnet Perspectives and Contributions to Theranostics.World journal of nuclear medicine · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Radiotheranostic landscape: A review of clinical and preclinical development.European journal of nuclear medicine and molecular imaging · 2025
    Review
  17. Review
  18. Powering the engine of nuclear medicine: insights from the next generation congress (Milan, 2024).European journal of nuclear medicine and molecular imaging · 2024
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Thomas N B PascualDepartment of Science and Technology, Manila, Philippines.ORCID 0000-0001-6444-7803
Diana PaezDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.ORCID 0000-0001-9268-0979
Andrei IagaruDivision of Nuclear Medicine and Molecular Imaging, Stanford University Medical Center, Stanford, CA, USA.ORCID 0000-0003-0839-5329
Gopi GnanasegaranDepartment of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, UK.ORCID 0000-0002-4617-9013
Sze Ting LeeDepartment of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.ORCID 0000-0001-8641-456X
Mike SathekgeSteve Biko Academic Hospital, Pretoria, South Africa.ORCID 0000-0002-2806-0625
John M BuattiDepartment of Radiation Oncology, Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.ORCID 0000-0001-8499-3721
Francesco GiammarileDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.ORCID 0000-0002-0550-7893
Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.ORCID 0000-0002-0978-4716
Manuela Arevalo PardoDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
Richard P BaumCenter for Advanced Radiomolecular Precision Oncology, Curanosticum Wiesbaden, FrankfurtWiesbaden, Germany.ORCID 0000-0003-1723-0075
Berardino De BariRadiation Oncology Department, Réseau Hospitalier Neuchâtelois, La Chaux-de-Fonds, Switzerland.ORCID 0000-0003-0117-3360
Simona Ben-HaimDepartment of Biophysics and Nuclear Medicine, Hadassah University Hospital, Jerusalem, Israel.ORCID 0000-0002-6111-1826
Jean-Yves BlayDepartment of Medicine, Centre Leon Berard, Lyon, France.ORCID 0000-0001-7190-120X
Anita BrinkDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.ORCID 0000-0001-8658-2379
Enrique Estrada-LobatoDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.ORCID 0000-0002-2597-8609
Stefano FantiNuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Policlinico S.Orsola, Bologna, Italy.ORCID 0000-0003-1486-2624
Anja Tea GolubicDepartment of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.ORCID 0000-0002-1113-3840
Jun HatazawaDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan.ORCID 0000-0003-1425-0521
Ora IsraelB. Rappaport School of Medicine, Israel Institute of Technology-Technion, Haifa, Israel.ORCID 0000-0001-6545-0924
Ana KiessDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-6928-3852
Peter KnollDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.ORCID 0000-0002-1249-922X
Jolanta KunikowskaNuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland.
Lizette LouwCenter of Molecular Imaging and Theranostics, Johannesburg, South Africa.ORCID 0000-0002-4146-2485
Giuliano MarianiRegional Center of Nuclear Medicine, Department of Translational Research and Advanced Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.ORCID 0000-0002-1900-4488
Siroos MirzaeiDepartment of Nuclear Medicine With PET-Centre, Clinic Ottakring, Vienna, Austria.ORCID 0000-0003-2861-6811
Pilar OrellanaPontificia Universidad Católica, Santiago, Chile.ORCID 0000-0001-7743-5836
John O PriorDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.ORCID 0000-0003-1429-1374
Jean-Luc UrbainRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Shrikant VichareDivision of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.ORCID 0009-0004-5854-0963
Sobhan VinjamuriNuclear Medicine Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.ORCID 0000-0003-3571-3273
Irene VirgoliniDepartment of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-7097-6170
Andrew M ScottDepartment of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia. andrew.scott@onjcri.org.au.ORCID 0000-0002-6656-295X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe recent development and approval of new diagnostic imaging and therapy approaches in the field of theranostics have revolutionised nuclear medicine practice. To ensure the provision of these new imaging and therapy approaches in a safe and high-quality manner, training of nuclear medicine physicians and qualified specialists is paramount. This is required for trainees who are learning theranostics practice, and for ensuring minimum standards for knowledge and competency in existing practising specialists.

methodsTo address the need for a training curriculum in theranostics that would be utilised at a global level, a Consultancy Meeting was held at the IAEA in May 2023, with participation by experts in radiopharmaceutical therapy and theranostics including representatives of major international organisations relevant to theranostics practice.

resultsThrough extensive discussions and review of existing curriculum and guidelines, a harmonised training program for theranostics was developed, which aims to ensure safe and high quality theranostics practice in all countries.

conclusionThe guiding principles for theranostics training outlined in this paper have immediate relevance for the safe and effective practice of theranostics.

Indexed as

Nuclear MedicineCurriculumHumansTheranostic NanomedicineCurriculumEducationTheranosticsTraining

Identifiers

PMID38453729
PMCPMC11178594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.